MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) — SEC Financial Statements & Analysis

MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) is a pharmaceutical preparations company, incorporated in DE. MARAVAI LIFESCIENCES HOLDINGS, INC. trades on Nasdaq as: MRVI. MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07. Based on that filing, MARAVAI LIFESCIENCES HOLDINGS, INC. carries a market cap of $923.50M, a P/E ratio of -6.17x, a P/B ratio of 2.60x, a P/S ratio of 4.42x, an enterprise value of $1.00B, and an EV/EBITDA multiple of -10.53x. On profitability, it posts a gross margin of 34.89%, an operating margin of -56.08%, a net margin of -71.74%, a Return on Equity (ROE) of -48.20%, a Return on Assets (ROA) of -19.96%, and a Return on Invested Capital (ROIC) of -31.92%. Per share, it reports EPS of $-1.01, diluted EPS of $-1.01, free cash flow per share of $-0.24, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -5.03% year-over-year, net income growth of -54.46% year-over-year, and EPS growth of -55.62% year-over-year. On the balance sheet, it maintains a current ratio of 4.05x, a quick ratio of 2.63x, working capital of $117.24M, a debt-to-equity ratio of 0.70x, a debt ratio of 0.41, an interest coverage ratio of -4.89x, free cash flow of $-35.84M (TTM), and net debt of $76.52M. Figures sourced from SEC EDGAR.

Market Cap

$923.50M

P/E TTM

-6.17x

EPS TTM

$-1.01

P/B TTM

2.60x

ROE TTM

-48.20%

ROA TTM

-19.96%

Debt To Equity

0.70x

Free Cash Flow TTM

$-35.84M

Net Revenue TTM Growth 1Y

-5.03%

Data as of 2026-06-30 · Source: SEC EDGAR